|
|
Article: Clinic Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Biother, of Eagan, Minn., said it completed a Phase I trial of Imprime PGG, its investigational drug for cancers and the enhancement of white blood cell mobilization and production. Results demonstrated a strong safety profile in 24 healthy volunteers following a single injection. The company plans to begin a Phase I study next month to generate additional safety data, including pharmacokinetic and pharmacodynamic data. Beyond that, Biothera expects to launch a Phase II program to include a series of trials featuring a combination of Imprime PGG and various monoclonal antibodies and growth factors to treat a number of indications.
o EntreMed Inc., of Rockville, ...